newsfilter
← Latest News
Business Wire·

Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

LogicBio acquisition to build on current collaborations and advancements in genomic medicine Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc.